Results 171 to 180 of about 68,914 (294)
Under varying conditions, autophagy plays a dualistic role in radiation‐induced brain injury (RIBI), interacting intricately with apoptosis, ferroptosis, neuroinflammation, oxidative stress, blood–brain barrier (BBB) disruption, mitophagy, endoplasmic reticulum (ER) stress, and mitochondrial biogenesis.
Jiayu Tian+6 more
wiley +1 more source
RACIAL EFFECTS ON THE SAFETY AND EFFICACY OF SIROLIMUS IN RENAL TRANSPLANTATION.
John F. Neylan, Jonathan S. Jaffe
openalex +1 more source
Coronary restenosis elimination with a sirolimus eluting stent; First European human experience with 6-month angiographic and intravascular ultrasonic follow-up [PDF]
Benno J. Rensing
openalex +1 more source
Sirolimus: A Potential Chemopreventive Agent [PDF]
Anthony P. Fernandez+2 more
openaire +3 more sources
ABSTRACT Background: Cardiac allograft vasculopathy (CAV) remains a barrier to long‐term survival after heart transplantation. Little is known about cardiovascular biomarkers in CAV and how they compare to biomarkers in atherosclerotic coronary artery disease (CAD).
Lukas Köster+12 more
wiley +1 more source
Transplacental sirolimus: a new treatment strategy for life-threatening fetal cardiac rhabdomyomas-a case report. [PDF]
Uno K+6 more
europepmc +1 more source
SIROLIMUS RESCUE THERAPY FOR REFRACTORY REJECTION IN RENAL TRANSPLANTATION.
Johnny Hong, Barry D. Kahan
openalex +1 more source
Prospective Monitoring of BK Virus Load after Discontinuing Sirolimus Treatment in a Renal Transplant Patient with BK Virus Nephropathy [PDF]
Hans H. Hirsch+2 more
openalex +1 more source
ABSTRACT Allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancies can cause acute and chronic graft‐versus‐host disease (GvHD), impacting graft success and mortality. Rabbit anti‐thymocyte globulin (r‐ATG) or post‐transplant cyclophosphamide (PTCy) is effective in reducing GvHD in haploidentical‐HSCT.
Joseph M. John+3 more
wiley +1 more source
Mortality in Tuberous Sclerosis Complex in the United Kingdom, 2016–2022
ABSTRACT Background Tuberous sclerosis complex (TSC) is a genetic condition caused by mutations in either TSC1 or TSC2 genes, affecting around two million people globally. This study aims to examine causes of death in TSC and explore factors contributing to mortality in people with TSC in the United Kingdom in recent years following updated management ...
Callum Richard Thomas Kidson+2 more
wiley +1 more source